US equities
|
MU
$938.09
▼-5.15%
META
$765.84
▲+3.08%
NVDA
$227.49
▲+0.52%
SNDK
$1,448.46
▼-2.61%
AAPL
$342.39
▲+0.42%
MSFT
$545.95
▲+0.89%
SPCX
$156.60
▼-4.17%
AMD
$599.18
▲+0.83%
MU
$938.09
▼-5.15%
META
$765.84
▲+3.08%
NVDA
$227.49
▲+0.52%
SNDK
$1,448.46
▼-2.61%
AAPL
$342.39
▲+0.42%
MSFT
$545.95
▲+0.89%
SPCX
$156.60
▼-4.17%
AMD
$599.18
▲+0.83%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Veklury
Recent news which mentions Veklury
Gilead Sciences: WHO Expands Recommendation for Veklury® (Remdesivir) to Patients With Severe Disease in Latest Update to COVID-19 Guideline
September 28, 2022
Tickers
GILD
Tags
NYSE:GILD
Veklury
Health & Healthcare
From
3BL Media: Corporate Social Responsibility, Energy and Health News